HeartSciences Inc. (HSCSW) stock
HSCSWNasdaqFinance ServicesFiscal year ends April 30Also trades as HSCS
$0.07−0.03 (-30.62%)
Close on Oct 30, 2026Market cap $15.89MP/E –Yield 0.00%
HeartSciences EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
HeartSciences's EPS for the twelve months ending Jul 31, 2026 was -$3.22. For fiscal 2025 it was -$9.34.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | -$9.34 | – |
| FY2024 | Apr 30, 2024 | -$18.74 | – |
| FY2023 | Apr 30, 2023 | -$80.00 | – |
| FY2022 | Apr 30, 2022 | -$145.00 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027 | Jul 31, 2026 | -$0.86 | – |
| Q4 FY2026 | Apr 30, 2026 | -$0.88 | – |
| Q3 FY2026 | Jan 31, 2026 | -$0.63 | – |
| Q2 FY2026 | Oct 31, 2025 | -$0.85 | – |
| Q1 FY2026 | Jul 31, 2025 | -$1.58 | – |
| Q4 FY2025 | Apr 30, 2025 | -$1.96 | – |
| Q3 FY2025 | Jan 31, 2025 | -$2.57 | – |
| Q2 FY2025 | Oct 31, 2024 | -$2.27 | – |
| Q1 FY2025 | Jul 31, 2024 | -$2.64 | – |
| Q3 FY2024 | Jan 31, 2024 | -$3.01 | – |
| Q2 FY2024 | Oct 31, 2023 | -$15.92 | – |
| Q1 FY2024 | Jul 31, 2023 | -$13.23 | – |
| Q4 FY2023 | Apr 30, 2023 | -$16.85 | – |
| Q3 FY2023 | Jan 31, 2023 | -$16.00 | – |
| Q2 FY2023 | Oct 31, 2022 | -$22.00 | – |
| Q1 FY2023 | Jul 31, 2022 | -$28.00 | – |
| Q4 FY2022 | Apr 30, 2022 | -$61.77 | – |
| Q3 FY2022 | Jan 31, 2022 | -$37.00 | – |
| Q2 FY2022 | Oct 31, 2021 | -$31.00 | – |
| Q1 FY2022 | Jul 31, 2021 | -$15.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics